| Literature DB >> 28753027 |
Corey M Griffith1, Preston B Williams2, Luzineide W Tinoco2,3, Meredith M Dinges2, Yinsheng Wang1,2, Cynthia K Larive1,2.
Abstract
Earthworm metabolism is recognized as a useful tool for monitoring environmental insults and measuring ecotoxicity, yet extensive earthworm metabolic profiling using 1H nuclear magnetic resonance (NMR) spectroscopy has been limited in scope. This study aims to expand the embedded metabolic material in earthworm coelomic fluid, coelomocytes, and tissue to aid systems toxicology research. Fifty-nine metabolites within Eisenia fetida were identified, with 47 detected in coelomic fluid, 41 in coelomocytes, and 54 in whole-worm samples and tissue extracts. The newly detected but known metabolites 2-aminobutyrate, nicotinurate, Nδ,Nδ,Nδ-trimethylornithine, and trigonelline are reported along with a novel compound, malylglutamate, elucidated using 2D NMR and high-resolution MS/MS. We postulate that malylglutamate acts as a glutamate/malate store, chelator, and anionic osmolyte and helps to provide electrolyte balance.Entities:
Keywords: NMR spectroscopy; coelomic fluid; coelomocytes; earthworm; high-resolution MS/MS; malylglutamate; metabolomics; structural elucidation
Mesh:
Substances:
Year: 2017 PMID: 28753027 PMCID: PMC5585853 DOI: 10.1021/acs.jproteome.7b00439
Source DB: PubMed Journal: J Proteome Res ISSN: 1535-3893 Impact factor: 4.466
List of Aqueous Metabolites and Their 1H Chemical Shifts Detected in Pooled and Individual Coelomic Fluid (CF), Coelomocytes (CC), and Tissue Extractsa
| no. | metabolite | coelomic fluid | coelomocytes | tissue | |
|---|---|---|---|---|---|
| 1 | acetate | a,b,e | a,b | a,b,e | 1.91 (s) |
| 2 | adenosine diphosphate | a,b,c,d | a,b,c,d | 4.22 (m), 4.38 (m), 4.53 (t), 6.14 (d), 8.25 (s), 8.52 (s) | |
| 3 | adenosine monophosphate | a,b,c,d | a,b,c,d | 4.01 (dd), 4.36 (dd), 4.50 (dd), 6.13 (d), 8.25 (s), 8.60 (s) | |
| 4 | adenosine triphosphate | a,b,c,d | a,b,c,d | 4.22 (m), 4.38 (m), 4.53 (t), 6.14 (d), 8.25 (s), 8.52 (s) | |
| 5 | alanine | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 1.47 (d), 3.78 (q) |
| 6 | asparagine | a,b,c,d | a,b,c,d | 2.91 (m), 4.01 (dd) | |
| 7 | aspartate | a,b,c,d | a,b,c,d | a,b,c,d,e | 2.74 (m), 3.89 (dd) |
| 8 | betaine | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 3.26 (s), 3.90 (s) |
| 9 | choline | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 3.21 (s), 3.52 (m), 4.07 (m) |
| 10 | cytosine | a,b,c,d | 5.95 (d), 7.49 (d) | ||
| 11 | formate | a,b,e | a,b | a,b,e | 8.44 (s) |
| 12 | fumarate | a,b,e | a,b,e | a,b,e | 6.50 (s) |
| 13 | glucose | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 3.23 (dd), 3.39 (m), 3.46 (m), 3.52 (dd), 3.73 (m), 3.82 (m), 4.83 (d), 5.22 (d) |
| 14 | glutamate | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 2.05 (m), 2.12 (m), 2.34 (m), 3.74 (q) |
| 15 | glutamine | a,b,c,d,e | a,b,c,d,e | a,b,c,d | 2.02 (m), 2.12 (m), 3.76 (t) |
| 16 | glycine | a,b,c,d | a,b,c,d,e | a,b,c,d,e | 3.54 (s) |
| 17 | glycerol | a,b,c,d,e | 3.60 (m), 3.77 (m) | ||
| 18 | glycerophosphocholine | a,b,e | a,b,e | a,b,e | 3.22 (s), 3.64 (m), 3.91 (m), 4.32 (m) |
| 19 | histidine | a,b,c,d | a,b,c,d | 3.13 (dd), 2.23 (dd), 3.97 (dd), 7.06 (d), 7.80 (d) | |
| 20 | histidine-betaine | a,b,e | a,b,e | a,e | 3.26 (s) |
| 21 | inosine | a,b,c,d | a,b,c,d | a,b,c,d | 3.83 (dd), 3.91 (dd), 4.27 (dd), 4.43 (dd), 6.09 (d), 8.23 (s), 8.33 (s) |
| 22 | isoleucine | a,b,c,d | a,b,c,d | a,b,c,d,e | 0.93 (t), 1.00 (d), 1.25 (m), 1.46 (m), 1.97 (m), 3.66 (d) |
| 23 | lactate | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 1.32 (d), 4.10 (q) |
| 24 | leucine | a,b,c,d | a,b,c,d | a,b,c,d,e | 0.95 (t), 1.71 (m), 3.72 (m) |
| 25 | lysine | a,b,c,d,e | 1.47 (m), 1.72 (m), 1.90 (m), 3.02 (t), 3.74 (t) | ||
| 26 | malate | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 2.36 (dd), 2.66 (dd), 4.29 (dd) |
| 28 | maltose-x | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 3.27 (dd), 3.41 (t), 3.58 (m), 3.63 (m), 3.66 (m), 3.70 (m), 3.76 (m), 3.84 (m), 3.90 (dd), 3.93 (d), 3.96 (m), 5.22 (d), 5.40 (d) |
| 29 | mannose | a,b,c,d | 3.37 (ddd), 3.56 (t), 3.65 (m), 3.74 (m), 3.80 (m), 3.84 (m), 3.88 (dd), 3.93 (m), 5.17 (m) | ||
| 30 | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 2.67 (t), 3.52 (dd), 3.61 (t), 4.05 (t) | |
| 31 | nicotinamide | a,b,c,d | 7.57 (m), 8.22 (m), 8.69 (dd), 8.90 (dd) | ||
| 32 | nicotinate | a,b,c,d | 7.51 (dd), 8.24 (m), 8.60 (dd), 8.93 (d) | ||
| 34 | a,b,c,d | a,b,c,d | a,b,c,d | 2.90 (s), 3.25 (dd), 3.86 (dd), 7.04 (s), 7.76 (s) | |
| 35 | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 1.46 (m), 1.89 (m), 3.11 (s), 3.34 (m), 3.75 (t) | |
| 37 | a,b,e | a,b,e | a,b,e | 3.19 (s) | |
| 38 | phenylalanine | a,b,c,d | a,b,c,d,e | 3.20 (m), 3.98 (dd), 7.32 (d), 7.36 (m), 7.42 (m) | |
| 39 | proline-betaine | a,b,e | 3.10 (s), 3.29 (s) | ||
| 40 | propionate | a,b,c,d | a,b,c,d | 1.05 (t), 2.17 (m) | |
| 41 | putrescine | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 1.76 (m), 3.05 (m) |
| 42 | pyruvate | a,b,e | a,b,e | a,b,e | 2.35 (s) |
| 43 | riboflavin | a,b,c,d,e | a,b,c,d,e | a,b,c,d | 2.47 (s), 2.58 (s), 3.72 (dd), 3.87 (dd), 3.92 (m), 3.97 (m), 4.43 (m), 4.95 (m), 5.13 (m), 7.95 (s), 7.97 (s) |
| 44 | a,b,e | a,b,e | a,b,e | 3.33 (s) | |
| 45 | spermidine | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 1.78 (m), 2.11 (m), 3.08 (m) |
| 46 | spermine | a,b,c,d,e | a,b,c,d,e | a,b,c,d,e | 1.82 (m), 2.12 (m), 3.11 (m) |
| 47 | succinate | a,b,e | a,b,e | a,b,e | 2.40 (s) |
| 48 | threonine | a,b,c,d | a,b,c,d,e | a,b,c,d,e | 1.32 (d), 3.57 (d), 4.24 (m) |
| 49 | trehalose | a,b,c,d | a,b,c,d | a,b,c,d | 3.44 (t), 3.64 (dd), 3.76 (m), 3.81 (m), 5.18 (d) |
| 51 | tyrosine | a,b,c,d | a,b,c,d,e | 3.05 (dd), 3.19 (dd), 3.93 (dd), 6.89 (m), 7.18 (m) | |
| 52 | uridine 5′-diphospho- | a,b,c,d | a,b,c,d | a,b,c,d | 2.07 (s), 3.55 (dd), 3.80 (m), 3.86 (dd), 3.92 (dd), 3.98 (tt), 4.21 (m), 4.28 (m), 4.36 (m), 5.51 (dd), 3.96 (d), 5.97 (d), 7.95 (d) |
| 53 | uridine | a,b,c,d | 3.79 (dd), 3.90 (dd), 4.12 (m), 4.22 (dd), 4.34 (dd), 5.89 (d), 5.91 (d), 7.86 (d) | ||
| 54 | valine | a,b,c,d | a,b,c,d | a,b,c,d,e | 0.98 (d), 1.03 (d), 2.27 (m), 3.60 (d) |
| 55 | α-ketoglutarate | a,b,c,d,e | a,b,c,d | a,b,c,d | 2.43 (t), 3.00 (t) |
| 56 | γ-butyrobetaine | a | a | 3.02 (m), 2.26 (t), 3.12 (s), 3.31 (m) | |
| 58 | 2-hexyl-5-ethyl-furan-3-sulfonate (HEFS)* | a,b,c,d,e | 0.84 (t), 1.17 (t), 1.28 (m), 1.63 (m), 2.58 (q), 2.82 (t), 6.17 (s) | ||
| 59 | 3-hydroxybutyrate | a,b,c,d | 1.18 (d), 2.29 (m), 2.39 (m), 4.13 (m) |
NMR spectra in which metabolites are confirmed are noted (a = 1D 1H NMR, b = 2D 1H J-Resolved, c = COSY, d = TOCSY, and e = 1H–13C HSQC) within each matrix. Bolded metabolites are new to earthworm metabolomics, and the spectra of authentic standards were not recorded for metabolites marked with an *.
Signal multiplicity is represented by s = singlet, d = doublet, dd = double doublet, m = multiplet, q = quartet, and t = triplet.
Figure 11H NMR spectra of 20-worm concentrated coelomic fluid (CF), 60-worm concentrated coelomocytes (CC), and 55 mg of pooled tissue extracts. The relative intensity of each region is listed on the right side of each spectrum. The spectra are divided into four regions: (A) 0.75–2.8, (B) 2.8–4.6, (C) 4.7–6.7, and (D) 6.7–9.2 ppm and resonances are annotated to their corresponding metabolite in Table . Several metabolites were identified but not annotated due to low intensity or because they were present in only a subset of samples.
Figure 2NMR spectra of unassigned resonances and comparison of closely related structures. (A) 1H NMR spectra of CC and the authenticated standards of glutamate (Glu), glutamylaspartate (Glu-Asp), aspartylglutamate (Asp-Glu), and N-acetylaspartylglutamate (NAAG) are stacked below and proton position is annotated. The two sets of unassigned resonances are annotated in the CC spectrum as 1H (green) and 2H (blue), and the malate (Mal) resonances are annotated in black. (B) TOCSY spectrum of CC annotated with the correlated spin systems of 1H, 2H, and Mal. (C) TOCSY spectrum of pooled CF sample at pD 3.18 in 90% H2O, revealing a strong correlation between an amide proton and a spin system resembling glutamate.
Figure 3Confirmation of malylglutamate in a diluted CF sample using positive-ion ESI–MS and MS/MS. (A) Positive-ion ESI–MS of malylglutamate (the calculated m/z 264.0719 for [M + H]+ ion) with its structure and (B) annotated MS/MS for the [M + H]+ ion of malylglutamate. * indicates a peak from an ion cofragmenting with the [M + H]+ ion.
Figure 4LC–MS identification of TMO and NMR confirmation. (A) N(CH3)3 singlets of TML and TMO between 3.05 and 3.15 ppm. (B) Positive-ion ESI–MS of TMO (the calculated m/z 175.1447 for the M+ ion); shown are the monoisotopic peak at m/z 175.1431 and the structure of TMO. (C) MS/MS for the M+ ion of TMO and (D) CF TOCSY spectrum with labeled TMO and TML spin systems. The TMO Nδ (CH3)3 and TML Nε(CH3)3 singlets are not correlated with these spin systems because the carbon-bound protons on either side of the nitrogen are too distant to be coupled to one another. Overlapped resonances of TML and alanine (Ala) are annotated to emphasize that the peak does not belong to the TMO spin system.
Figure 5Chemical structures of (A) malylglutamate, (B) β-citrylglutamate, (C) N-acetylaspartylglutamate (NAAG), and (D) 1,3,4,6-tetracarboxyhexane.